These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21962770)

  • 21. Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening program.
    Rawlinson WD; Palasanthiran P; Hall B; Al Yazidi L; Cannon MJ; Cottier C; van Zuylen WJ; Wilkinson M
    J Clin Virol; 2018 May; 102():110-115. PubMed ID: 29571077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir.
    Meine Jansen CF; Toet MC; Rademaker CM; Ververs TF; Gerards LJ; van Loon AM
    J Perinat Med; 2005; 33(4):364-6. PubMed ID: 16211780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of a Targeted Screening Program for Congenital Cytomegalovirus Infection in Infants Who Fail Newborn Hearing Screening.
    Vancor E; Shapiro ED; Loyal J
    J Pediatric Infect Dis Soc; 2019 Mar; 8(1):55-59. PubMed ID: 29373759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment.
    Nishida K; Morioka I; Nakamachi Y; Kobayashi Y; Imanishi T; Kawano S; Iwatani S; Koda T; Deguchi M; Tanimura K; Yamashita D; Nibu K; Funakoshi T; Ohashi M; Inoue N; Iijima K; Yamada H
    Brain Dev; 2016 Feb; 38(2):209-16. PubMed ID: 26282917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital Cytomegalovirus Pneumonitis and Treatment Response Evaluation Using Viral Load during Ganciclovir Therapy: a Case Report.
    Lee-Yoshimoto M; Goishi K; Torii Y; Ito Y; Ono H; Mori T; Kashiwa N; Hosokawa S; Shichino H
    Jpn J Infect Dis; 2018 Jul; 71(4):309-311. PubMed ID: 29709989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for seemingly healthy newborns with congenital cytomegalovirus infection by quantitative real-time polymerase chain reaction using newborn urine: an observational study.
    Yamaguchi A; Oh-Ishi T; Arai T; Sakata H; Adachi N; Asanuma S; Oguma E; Kimoto H; Matsumoto J; Fujita H; Uesato T; Fujita J; Shirato K; Ohno H; Kizaki T
    BMJ Open; 2017 Jan; 7(1):e013810. PubMed ID: 28110288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of targeted saliva screening for congenital CMV-related hearing loss in newborns who fail hearing screening.
    Ari-Even Roth D; Lubin D; Kuint J; Teperberg-Oikawa M; Mendelson E; Strauss T; Barkai G
    Arch Dis Child Fetal Neonatal Ed; 2017 Nov; 102(6):F519-F524. PubMed ID: 28468898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection.
    Pati SK; Pinninti S; Novak Z; Chowdhury N; Patro RK; Fowler K; Ross S; Boppana S;
    Pediatr Infect Dis J; 2013 Oct; 32(10):1050-4. PubMed ID: 23694837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically targeted screening for congenital CMV - potential for integration into the National Hearing Screening Programme.
    Kadambari S; Luck S; Davis A; Williams E; Berrington J; Griffiths P; Sharland M
    Acta Paediatr; 2013 Oct; 102(10):928-33. PubMed ID: 23927434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.
    Kimberlin DW; Acosta EP; Sánchez PJ; Sood S; Agrawal V; Homans J; Jacobs RF; Lang D; Romero JR; Griffin J; Cloud GA; Lakeman FD; Whitley RJ;
    J Infect Dis; 2008 Mar; 197(6):836-45. PubMed ID: 18279073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial.
    Kimberlin DW; Aban I; Peri K; Nishikawa JK; Bernatoniene J; Emonts M; Klein N; Bamford A; DeBiasi RL; Faust SN; Jones CE; McMaster P; Caserta M; Ahmed A; Sharland M; Demmler-Harrison G; Hackett S; Sánchez PJ; Shackley F; Kelly D; Dennehy PH; Storch GA; Whitley RJ; Griffiths P;
    J Pediatr; 2024 May; 268():113934. PubMed ID: 38309519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?
    Yamamoto AY; Mussi-Pinhata MM; Marin LJ; Brito RM; Oliveira PF; Coelho TB
    J Clin Virol; 2006 Jul; 36(3):228-30. PubMed ID: 16750653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valganciclovir treatment in a 6-month-old infant with asymptomatic congenital cytomegalovirus infection and late hearing loss.
    Stronati M; Garofoli F; Angelini M; Licari A; Manzoni P; Lombardi G
    Pediatr Infect Dis J; 2011 Dec; 30(12):1124-5. PubMed ID: 22105427
    [No Abstract]   [Full Text] [Related]  

  • 34. Congenital cytomegalovirus infection: current strategies and future perspectives.
    Buonsenso D; Serranti D; Gargiullo L; Ceccarelli M; Ranno O; Valentini P
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):919-35. PubMed ID: 22953641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening newborns for congenital cytomegalovirus infection.
    Bale JF
    JAMA; 2010 Apr; 303(14):1425-6. PubMed ID: 20388901
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay.
    Nagel A; Dimitrakopoulou E; Teig N; Kern P; Lücke T; Michna D; Korn K; Steininger P; Shahada K; Neumann K; Überla K
    PLoS One; 2020; 15(1):e0227143. PubMed ID: 31917817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
    Boppana SB; Ross SA; Shimamura M; Palmer AL; Ahmed A; Michaels MG; Sánchez PJ; Bernstein DI; Tolan RW; Novak Z; Chowdhury N; Britt WJ; Fowler KB;
    N Engl J Med; 2011 Jun; 364(22):2111-8. PubMed ID: 21631323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns.
    Lanari M; Lazzarotto T; Venturi V; Papa I; Gabrielli L; Guerra B; Landini MP; Faldella G
    Pediatrics; 2006 Jan; 117(1):e76-83. PubMed ID: 16326692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period.
    del Rosal T; Baquero-Artigao F; Blázquez D; Noguera-Julian A; Moreno-Pérez D; Reyes A; Vilas J
    J Clin Virol; 2012 Sep; 55(1):72-4. PubMed ID: 22750017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal screening for congenital cytomegalovirus infection and hearing loss.
    Barbi M; Binda S; Caroppo S; Primache V
    J Clin Virol; 2006 Feb; 35(2):206-9. PubMed ID: 16384745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.